Anemia, renal dysfunction, and their interaction in patients with chronic heart failure

被引:104
作者
de Silva, Ramesh [1 ]
Rigby, Alan S.
Witte, Klaus K. A.
Nikitin, Nikolay P.
Tin, Lwin
Goode, Kevin
Bhandari, Sunil
Clark, Andrew L.
Cleland, John G. F.
机构
[1] Univ Hull, Castle Hill Hosp, Cottingham, England
[2] Hull Royal Infirm, Dept Nephrol, Kingston Upon Hull HU3 2JZ, N Humberside, England
关键词
D O I
10.1016/j.amjcard.2006.01.107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anemia and renal dysfunction (RD) are frequent complications seen in chronic heart failure (HF). However, the prevalence and interaction of these co-morbidities in a representative population of outpatients with chronic HF is poorly described. In this study, it was sought to determine the association between RD and anemia in patients with HF enrolled in a community-based HF program. Nine hundred fifty-five patients with HF due to left ventricular systolic dysfunction were investigated for the prevalence of anemia and its cause and followed for a median of 531 days. Anemia was defined as hemoglobin < 12.0 g/dl in women and < 13.0 g/dl in men. RD was defined as a calculated glomerular filtration rate of < 60 ml/min. The prevalence of anemia was 32%. Fifty-three percent of patients with and 27% of those without anemia had >= 1 test suggesting hematinic deficiency. The prevalence of RD was 54%. Forty-one percent of patients with and 22% of patients without, RD had anemia, with similar proportions associated with iron deficiency in the presence or absence of RD. Anemia and RD independently predicted a worse outcome, and this effect was additive. In conclusion, in outpatients with chronic HF, anemia and RD are common and co-exist but confer independent prognostic information. A deficiency of conventional hematinic factors may cause about 1/3 of anemia in this clinical setting. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 30 条
[1]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[2]  
Altman D., 2000, STAT CONFIDENCE
[3]  
*AMG DEV EUR, 2001, STUD ASS PHAR PHARM
[4]   Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy [J].
Bhandari, S ;
Norfolk, D ;
Brownjohn, A ;
Turney, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (06) :814-821
[5]   Commentary: Facing the challenge of gene-environment interaction: The two-by-four table and beyond [J].
Botto, LD ;
Khoury, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (10) :1016-1020
[6]   Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? [J].
Cromie, N ;
Lee, C ;
Struthers, AD .
HEART, 2002, 87 (04) :377-378
[7]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[8]   Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure [J].
Ezekowitz, JA ;
McAlister, FA ;
Armstrong, PW .
CIRCULATION, 2003, 107 (02) :223-225
[9]   Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure [J].
Felker, GM ;
Gattis, WA ;
Leimberger, JD ;
Adams, KF ;
Cuffe, MS ;
Gheorghiade, M ;
O'Connor, CM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :625-628
[10]  
Goch J, 1996, NEPHRON, V73, P403